SAR - Profile Therapeutics
19 3월 2004 - 8:34PM
UK Regulatory
RNS Number:7237W
3i Investments PLC
19 March 2004
FORM SAR 5
Lodge with Company Announcements Office and the Panel.
A copy must also be sent to the company the shares of which are being sold.
Date of disclosure
19.03.04
DISCLOSURE UNDER NOTE 3 OF RULE 5 OF THE RULES GOVERNING SUBSTANTIAL
ACQUISITIONS OF SHARES ("SARs")
Date of sale
18.03.04
Sale of (name of company)
Profile Therapeutics plc
1. Class of voting shares (eg ordinary shares)
Ordinary 2p shares
Number of shares/rights over shares sold
1,000,000 Shares Rights
If rights over shares sold, as opposed to the shares themselves, specify nature
of rights
2. Resultant total holding of voting shares (and % of total voting shares in
issue)
9,516,384 19.38 %
Resultant total holding of rights over shares (and % of total voting shares in
issue)
%
Total percentage
19.38 %
3. Party making disclosure
3i Investments plc
4. (a) Name of person selling shares or rights over shares
3i Investments plc
and, if different, beneficial owner
(b) Names of any other persons acting by agreement or understanding
Signed, for and on behalf of the party named in (3) above
(Also print name of signatory)
Simon Howard
Telephone and extension number
020 7928 3131
For full details of the SARs disclosure requirements, see Rules 3 and 5 of the
SARs. If in doubt, contact the Panel on Takeovers and Mergers, Monitoring
Section, Tel. No: 020 7638 0129.
This information is provided by RNS
The company news service from the London Stock Exchange
END
SADILFFLVAIALIS
Profile Thera. (LSE:PTP)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Profile Thera. (LSE:PTP)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024
Profile Thera. (London Stock Exchange)의 실시간 뉴스: 최근 기사 0
More Profile Therapeutics News Articles